Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 37169

AbstractMaterial and MethodsResultsDiscussionConclusionAcknowledgementReferences
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2007 | Month : December | Volume : 1 | Issue : 6 | Page : 454 - 459 Full Version

Prenatal Diagnosis (PND) of β-Thalassemia in the Khuzestan Province, Iran


Published: December 1, 2007 | DOI: https://doi.org/10.7860/JCDR/2007/.139
RAHIM F* **, KEIKHAEI B**, ABERUMAND M***

*Research Center of Physiology, Ahwaz Jondishapur University of Medical Sciences, Ahwaz Iran,**Research Centers of Thalassemia and Hemoglobinopathies, Ahwaz Jondishapur University of Medical Sciences, Ahwaz, Iran,***Department of Biochemistry, Ahwaz Jondishapur University of Medical Sciences, Ahwaz, Iran

Correspondence Address :
Fakher Rahim. Research Center of Physiology, Ahwaz Jondishapur University of Medical Sciences, Ahwaz, Iran.
Tel.: +989163102183; fax: +986113367562; e-mail: Fakherraheem@yahoo.com

Abstract

β -Thalassemia is present in practically every caste group in Iran. Khuzestan is located in the southern part of the geographical region of Iran. The β-thalassemia incidence in the Khuzestan province is between 2.6-3.7%, as reported by different researchers. Reverse dot blot hybridization and Amplification Refractory mutation Analysis (ARMS), were used to scan the entire β -globin gene to localize the mutation, followed by DNA sequencing for characterization. The DNA samples from 254 subjects (127 thalassemia patients and 127 choronic villi samples) had been referred to us at the Research Center of Thalassemia and Hemoglobinopathies of Ahwaz Jondishapur University of medical sciences, Iran. According to our study, CD 36/37 (-T) and IVS 2-1 (G to C) were the most frequent mutation types (14.7 %) in our province, the same as in other geographical regions of Iran. Also, the most predominant mutations which lead to termination of pregnancy of those couples in the first trimester of first pregnancy, CD 6 or HbS (22.5 %), IVS 2-1 (17.5%), CD 36/37 (15%), CD 44(12.5%), and IVSI-110 (12.5 %) mutations, were detected in 40 foetuses, and compound heterozygosity was detected in various combinations for IVSI-110, IVSII-745, IVSI-6, IVSI-1, IVSII-1, IVSI-5, IVSI-130, CD 8. HbS mutations were detected in 13 foetuses, who were later aborted, with the written permission of their families. In conclusion, our preliminary results show the heterogeneity of the β -thalassemia mutations in the province of Khuzestan. Our data is valuable, in that it includes the mutation screening of patients for prenatal diagnosis in Khuzestan and nearby towns and villages, one of the regions with the highest frequency of β -thalassemia mutations in Iran. In addition to discovering novel and rare mutations in the rich genetic pool of our region, this study was carried out in order to reduce the frequency of consanguineous marriages and haemoglobinopathies, to educate the population, and to inform the physicians in our region.

Keywords

β- thalassemia, reverse dot blot hybridization, amplification refractory analysis (ARMS), Iran, PCR

Iran, whose area is 1,648,000 km sq, has a large number of thalassemia major patients like many other countries in the region (1). The gene frequency of β-thalassemia, however, is high, and varies considerably from area to area, having its highest rate of more than 10% around the Caspian Sea and the Persian Gulf. The prevalence of the disorder in other areas is between 4-8%. In Isfahan, a city built around the river Zayandeh-Rood in the central part of Iran, the frequency rises again to about 8%. In the Fars Province, in southern Iran, the gene frequency is also high, and reaches 8-10% (1). The region investigated was the province of Khuzestan, located in the southern part of Iran on the Mediterranean Sea, comprising coastal and mountainous areas, with a population of 4.3 million in 10 counties. More than 23 different molecular defects have been identified for β-thalassemia, till date. The case of β-thalassemia, with over 150 various known mutations, is even more perplexing (2). Each population-at-risk, however, has its own spectrum of common mutations, usually from five to ten, a finding that simplifies mutation analysis and thus determines the origin of mutant genes. Thalassemia is found in some 60 countries, with the highest prevalence in the Mediterranean region, parts of North and West Africa, the Middle East, the Indian subcontinent, southern Far East and southeastern Asia, together comprising the so-called thalassemia belt. In western countries, thalassemia affects mostly individuals whose ancestry is traceable to high-prevalence areas (3),(4),(5), (6). As an example, there are around 1,000 cases of β-thalassemia major in the United States, most of whom are descendants of Mediterranean, Asian Indian, South Asian or Chinese ancestors (3). This figure is even less than half of the number of β-thalassemic patients in Fars Province, a region only 120,000 km sq large in southern Iran (7). As there is no ultimate cure for this hereditary disease, the World Health Organization (WHO) has suggested a control program which comprises of raising public awareness about the disease, screening for carriers, prenatal diagnosis and genetic counseling, which would result in the prevention of the birth of an affected child. Italy, Greece, Canada, the United Kingdom and Cyprus started the program in the 1970’s, and achieved success (8),(9),(10),(11),(12),(13),(14), (15). Although historically, the prevention program, abortion, was considered unacceptable in Iran, intensive consultation led to the clerical approval of induced abortion in cases with β-thalassemia major in 1997, and a nationwide prevention program with screening, counseling and prenatal diagnosis (PND) network has been developed (16). Due to the high consanguinity rate and high frequency of β-globin gene mutation carriers, a prenatal diagnosis program was needed, and we set up a laboratory to screen the globin gene mutations, at The Research Center of Thalassemia and Hemoglobinopathies of Ahwaz Jondishapur University of Medical Sciences, Iran. Two renowned Islamic clerics who were consulted before the service was introduced, ruled that a pregnancy can be terminated if the foetus is affected by serious genetic disorders, and if termination is before 90 days (12 weeks) of gestation. The prenatal diagnosis is performed by several molecular methods, by using samples like chorionic villi (CV), amniotic fluid, and cord blood

Material and Methods

We received a total of 381 DNA samples from patients (254 thalassemia traits) and prenatal cases (127 choronic villi samples), from various geographic areas and ethnic groups within the Khuzestan province, between 2002 -2006. Blood was collected into EDTA, and red cell indices were obtained from a Coulter AcT. In cases with a mean corpuscular volume (MCV) of ≤80 fl, HbA2 and HbF were determined by column chromatography and alkali denaturation, respectively. Haemoglobin electrophoresis was carried out on cellulose acetate and agar gel. Cases with MCV<80 fl, HbA2≥3.5%, and HbF≥2%, were considered to have the β-thalassemia trait. Those cases with normal HbA2 with MCV<80 fl, were sent for further evaluation to haematology clinics. If the couples were both carriers of an abnormal haemoglobin or β-thalassemia gene, they were informed confidentially about their test results, and were counseled about the reproductive options and about obtaining prenatal diagnosis.

As our first approach, the samples were screened for a panel of 22 relatively common β- globin mutations using an assay based on the polymerase chain reaction (PCR) and reverse- hybridization, by using oligonucleotide arrays immobilized on test strips (17). They were asked to come to the center in the case of pregnancy, and the PND test was done for the fetuses, by choronic villus sampling. Foetal DNA is usually and preferably, obtained through choronic villus sampling in the first trimester of pregnancy (10-12 weeks) (16). Chorionic villus sampling provides a good yield of DNA, which is isolated using the conventional method of phenol chloroform extraction, after careful microscopic dissection to remove any contaminating maternal deciduas. The CV sample was used for screening β-globin gene mutations. The reverse dot blot hybridization (RDBH) kit (22 mutations for Beta-globin Strip Assay, VienLab), Amplification Refractory mutation Analysis (ARMS),and dideoxy termination chain of DNA sequencing, were used to determine the mutations of the β-globin gene (18). When the mutation found in the foetus was the same as found in her/his mother, a variable number of tandem repeat (VNTR) markers (ApoB, MCT, IgJH, and D4S95) were used to avoid maternal contamination (19).

Results

In the study period, 127 subjects and 127 foetuses were screened for haemoglobinopathies in the province of Khuzestan. All subjects (254 samples) involving thalassemia patients and prenatal DNA samples, were initially tested for 22 common mutations by reverse–hybridization, and if negative, further analyzed by DNA sequencing of the entire β-globin gene. A total of 18 different mutations discovered by this two-step approach, are listed, including the number of chromosomes, and heterozygous and homozygous cases (Table/Fig 1). The results are listed in (Table/Fig 1) (170 affected chromosomes and 84 normal chromosomes). Our study showed that 77 patients out of 127, and 53 foetuses out of 127, were affected. CD 36/37 (-T) and IVS 2 (G to C) were the most frequently observed β-thalassemia mutations (14.7 %) for each type, followed by CD 6 or HbS (13 %) , IVSI-110 (8.8 %), IVS I -6(T to C) (5.89%), CD 44 (-C) (4.7%), IVSI-5(G to C) (3.5%), CD 39 (C to T) (2.35%), Fr 8/9 (+G) (2.35%), IVS II-745 (C to G) (2.35%), IVS I-1(G to A) (2.35%), IVS 1( 3' end) -25bp (2.35%), and CD 8(-AA) (1.8%). Homozygosity for IVSI- 110, CD 36/37, IVSI-1, IVSI-6, CD 44, CD 8, CD 8/9, IVSI-5, and IVS 1(3' end)-25bp mutations (Table/Fig 2), were detected in 40 foetuses, and compound heterozygosity was observed in various combinations for IVSI-110, IVSII-745, IVSI-6, IVSI-1, IVSII-1, IVSI-5, IVSI-130, CD 8. HbS mutations (Table/Fig 3) were detected in 13 foetuses, who were later aborted, with the written permission of the families. Twenty-three foetuses were found to be heterozygous for the above mentioned mutations, and the remaining foetuses were found to have the normal genotype for the β-globin gene.

Discussion

Haemoglobinopathies are a major public health problem, causing both severe socio-economic and psychological debilitation in the population due to symptomatic care and hospitalization. Therefore, since 2002, we have been performing prenatal diagnosis for β-thalassemia, which is seen frequently in the Khuzestan Province of the country, in our molecular genetic laboratories. In recent years, there has been an increase in the number of β-thalassemia cases, as was presented in conferences and seminars by experts to the public. As a result, 127 CV samples for prenatal diagnosis were analyzed at 9-12 weeks. All of the CV samples could evaluate for beta-globin gene mutations. There was no miscarriage after CV sampling. All 40 affected foetuses were aborted according to the decision of the parents. The results of the molecular prenatal diagnoses were available within 4+1 days after sampling. To eliminate the risk of maternal contamination, VNTR analysis using ApoB, MCT, IgJH, and D4S95 alleles was performed, when the genotype of the foetus was found to be identical to that of the mother (25). There has been no misdiagnosis in our laboratory, till date. A 15-20 minute genetic counseling seems insufficient for those who are informed of these diseases just before phlebotomy, or when they receive the test results. These data show that the public is not well informed about these genetic diseases. Enlightenment of the public and the support of government, are the leading criteria for the preventive measures. The meaning of the carrier status should be made well known to the public, long before the age of marriage. As noted by Modell, Cao, Mitchell, and Loutradi-Anagnostou, co-operation of the government and non-government organizations, leaders in the community, parent organizations at schools, religious leaders, and local health personnel, are the prerequisites for the education of the public in this regard. With the help of these organizations, along with premarital screening programs, fewer affected births were observed in recent years in the United Kingdom, Italy, Canada, and Cyprus (20),(21),(22),(23),(24). Scriver’s group achieved almost a 90-95% success in informing high school students about such genetic diseases, utilizing similar organizations, voluntary screening, and genetic counseling over a 20-year span in Canada (23). In the United Kingdom, the utilization of prenatal diagnosis, which was 20% from 1974-1994, had risen to 80% by 2000 (20),(21). In this screening survey, 53 homozygous babies would possibly not have been born, if the couples had been well informed, had health insurance coverage, and had been given the opportunity for undergoing prenatal diagnosis in all pregnancies. Our results show similarities with those of other groups that study the prenatal diagnosis of β-thalassemia and sickle cell anemia (26),(27),(28).

Conclusion

In conclusion, our data is valuable, in that it includes the screening for mutations in patients who were selected for prenatal diagnosis in Khuzestan and nearby towns and villages, one of the regions with the highest frequency of beta-thalassemia mutations in Iran. Also, we aim to record all the carriers and patients for β-thalassemia, using a program via the Research Center of Thalassemia and Hemoglobinopathies of Ahwaz Jondishapur University of Medical Sciences, Iran, in addition to discovering novel and rare mutations in the rich genetic pool of our region, in order to reduce the frequency of consanguineous marriages and haemoglobinopathies, to educate the population, and inform the physicians in our region.

Acknowledgement

This work was supported by Prof. Mohammad Pedram, the HOD and Director of the Research Centers of Thalassemia and Hemoglobinopathies, Ahwaz Jondishapur University of Medical Sciences, Ahwaz, Iran, Prof. Khodamoard Zandian, and Dr Mohammad Taghi Akbari, the Director of Tehran Medical Genetic Lab.

References

1.
Haghshenas M, Zamani J. [Thalassemia]. 1 st ed. Shiraz University of Medical Sciences Publishing Center: Shiraz; 1997. [Book in Persian].
2.
Cao A, Saba L, Galanello R, Rosatelli MC. Molecular diagnosis and carrier screening for beta thalassemia. JAMA 1997; 278:1273-7.
3.
Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state. Genet Epidemiol 1996; 13:501-12.
4.
Birgens HS, Karle H, Guldberg P, Guttler F. Hemoglobinopathy in the county of Copenhagen. Ugeskr Laeger 1997;159:3934-9.
5.
Vetter B, Schwarz C, Kohne E, Kulozik AE. Beta-thalassemia in the immigrant and non-immigrant German populations. Br J Haematol 1997; 97:266-72.
6.
Rengelink-van der Lee JH, Schulpen TW, Beemer FA. Incidence and prevalence of hemoglobinopathies in children in The Netherlands. Ned Tijdschr Geneeskd 1995; 139:1498-501.
7.
Weatherall DJ, Clegg JB. The thalassemia syndromes. 4 th ed. Blackwell Scientific: 2001.
8.
Cao A, Pirastu M, Rosatelli MC. The prenatal diagnosis of thalassaemia. Br J Haematol 1986; 63:215-20.
9.
Cao A, Galanello R, Rosatelli MC, Argiolu I, De Virgilis S. Clinical experience of management of thalassemia: the Sardinian experience. Sem Haematol 1996; 33:66-75.
10.
Scriver CR, Bardanis M, Cartier L, Clow CL, and Lancaster GA, Ostrowsky JT. β-thalassemia disease prevention: genetic medicine applied. Am J Hum Genet 1984; 36:1024-38.
11.
Old JM, Varawalla NY, Weatherall DJ. Rapid detection and prenatal diagnosis of β-thalassaemia studies in Indian and Cypriot populations in the UK. Lancet 1990; 6:834-7.
12.
Modell B, Petrou M, Layton M, Varnavides L, Slater C, Ward RHT, Rodeck C, Nicolaides K, Gibbons S, Fitches A, Old J. Audit of prenatal diagnosis for haemoglobin disorders in the United Kingdom: the first 20 years. Br Med J 1997; 315:779-83.
13.
Angastiniodis M, Kyriakidou S, Hadjimin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com